India, May 20 -- Merit Medical Systems, Inc. (MMSI), a healthcare technology company, Tuesday said that it has acquired Biolife Delaware, L.L.C. for about $120 million in cash.
Through the acquisition, Biolife, a maker of hemostatic devices, has become the wholly-owned subsidiary of Merit.
The transaction is expected to be slightly dilutive to the company's full-year adjusted profitability given the partial-year contribution.
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1568189509843-0'); });
Additionally, the company has reiterated its full-year outlook.
"The acquisition provides effective, differentiated, hemostatic solutions for all percutaneous devices with a broad range of clinical applications including vascular ...